Finance

Lists
OL0:FRA
Devyser Diagnostics AB
€5.66
0.00%
(0.00) 1D
Nov 17, 3:25:02 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OL0...
Mkt. cap
1.07B
Avg. vol.
0.00
Volume
0.00
52-wk high
€10.80
52-wk low
€4.36
No. of employees
111
Mkt. cap
1.07B
Avg. vol.
0.00
Volume
0.00
52-wk high
€10.80
52-wk low
€4.36
No. of employees
111
News stories
From web sources and news partners
About Devyser Diagnostics AB
CEO-
Employees111
Founded2004
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
72.00M
61.80M
60.20M
59.70M
Cost of goods sold
14.80M
11.30M
14.40M
10.10M
Cost of revenue
14.80M
11.30M
14.40M
10.10M
Research and development expenses
2.50M
5.40M
6.30M
3.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.60M
42.30M
39.70M
39.30M
Operating expense
38.10M
47.70M
46.00M
42.90M
Total operating expenses
52.90M
59.00M
60.40M
53.00M
Operating income
19.10M
2.80M
-200.00K
6.70M
Other non operating income
-
100.00K
200.00K
-200.00K
EBT including unusual items
16.00M
4.40M
1.60M
8.70M
EBT excluding unusual items
16.00M
4.40M
1.60M
8.70M
Income tax expense
2.40M
1.50M
-
1.40M
Effective tax rate
15.00%
34.09%
-
16.09%
Other operating expenses
-1.00M
-
-
-100.00K
Net income
13.60M
2.90M
1.60M
7.30M
Net profit margin
18.89%
4.69%
2.66%
12.23%
Earnings per share
-
-
-
-
Interest and investment income
8.60M
2.50M
1.70M
2.30M
Interest expense
-
-700.00K
-700.00K
-600.00K
Net interest expenses
8.60M
1.80M
1.00M
1.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
24.50M
8.10M
5.10M
12.00M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps